Catalyst OrthoScience, a medical device company focused on the upper limb orthopedics market, recently appointed David Sharp as Vice President of Global Marketing, effective immediately.
The appointment comes three months after the Naples-based company named medical device industry leader Carl O’Connell as president and chief executive officer.
Sharp brings to his new role more than 27 years of experience in marketing, strategy, business development, communications and branding in the medical device industry. Companies he has worked for include Sofamor Danek, Smith & Nephew, Medtronic Spinal & Biologics, Baxter International and, most recently, MicroPort Orthopedics, according to a statement.
“We are thrilled to have an executive with David’s experience join our team at Catalyst OrthoScience,” O’Connell said in the release. “As we continue to grow and establish our presence as an emerging global leader in shoulder pathology solutions, David’s leadership and experience will help make this vision a reality.”
Catalyst OrthoScience, whose goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for surgeons and patients, has a growing portfolio of patents and patents pending on its distinctive surgical offerings. Its products are available across the United States. In 2021, it both obtained FDA approval for its innovative new reverse shoulder implant system and closed a $12.5 million funding round.
“I am thrilled to join the Catalyst team and contribute to the company’s goals which focus on sustainable growth and providing real solutions to the unmet clinical needs of shoulder surgeons and their patients around the world. “Sharp said in the statement. “I will focus on growing a top-notch marketing team and brand as we continue to build our core foundations in sales, marketing, R&D and MedEd.”